Michael Katcher, MD
Cardiovascular Disease · Salem, MANPI 1417939455
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $109,764 of the $113,376 with a category attached, or 96.8%. Abbott accounts for 92.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $28,447 and has fallen 63.8% since, to $10,293 in 2025. Among cardiovascular disease clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $1206.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$105K
- Preventice Services, LLC$8K
- Medtronic$80
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$31
- Boston Scientific$21
- Biotronik Inc.$20
Across 27 payments — averaging $3100.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Atricure, Inc.$84K
What the payments were for
- Consulting fees$109,76497%
- Travel & lodging$2,9423%
- Food & beverage$6391%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 85 | $104,870 |
| Preventice Services, LLC | 3 | $8,355 |
| Medtronic(2 entities) | 2 | $80 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $31 |
| Boston Scientific | 1 | $21 |
| Biotronik Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Confirm Rx$52,750
- AVEIR$12,097
- Fortify Assura, Ellipse ICD$10,840
- Allure CRT Pacemaker$10,481
- Accent Pacemaker$9,975
- GALLANT$4,010
- Gallant ICD$2,850
- TENDRIL$500
- Agilis NxT EP Introducer$475
- Tendril Pacing Lead$238
- Quadra Assura CRT Defibrillator$129
How this compares
$113,376 in reported general payments places this provider in the 90th percentile of 750 cardiovascular disease providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 56 | $75,098 |
| Metoprolol Succinate | 126 | $2,481 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $913 |
| Atorvastatin Calcium | 51 | $759 |
| Ezetimibe | 16 | $678 |
| Rosuvastatin Calcium | 12 | $368 |
| Amiodarone Hcl | 17 | $220 |
| Cephalexin | 77 | $210 |
| Amlodipine Besylate | 16 | $81 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Salem
- Marc SabatineBoston$3.9M
- Elizabeth NabelBoston$2.2M
- Kenneth RosenfieldBoston$1.4M
- Kevin CroceChestnut Hill$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
- Paul RidkerBoston$572K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.